Group One Trading LLC purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 90,331 shares of the exchange traded fund’s stock, valued at approximately $11,538,000. Group One Trading LLC owned approximately 0.14% of SPDR S&P Biotech ETF at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Financial Life Planners purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in SPDR S&P Biotech ETF in the 4th quarter worth $27,000. Intesa Sanpaolo Wealth Management acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $30,000. SHP Wealth Management acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $31,000. Finally, Legacy Wealth Managment LLC ID acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth about $32,000.
SPDR S&P Biotech ETF Stock Performance
SPDR S&P Biotech ETF stock opened at $152.11 on Thursday. The business’s 50-day simple moving average is $143.49 and its two-hundred day simple moving average is $133.10. The company has a market cap of $10.21 billion, a PE ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a fifty-two week low of $84.39 and a fifty-two week high of $165.71.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Read More
- Five stocks we like better than SPDR S&P Biotech ETF
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
